Welcome to LookChem.com Sign In|Join Free

CAS

  • or

239074-29-4

Post Buying Request

239074-29-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • SAGECHEM/ tert-Butyl (trans-4-(hydroxymethyl)cyclohexyl)carbamate /Manufacturer in China

    Cas No: 239074-29-4

  • No Data

  • No Data

  • Metric Ton/Day

  • SAGECHEM LIMITED
  • Contact Supplier

239074-29-4 Usage

Description

TERT-BUTYL TRANS-(4-HYDROXYMETHYL)CYCLOHEXYLCARBAMATE is a chemical compound that serves as an intermediate in the synthesis of various pharmaceuticals and bioactive molecules.

Uses

Used in Pharmaceutical Industry:
TERT-BUTYL TRANS-(4-HYDROXYMETHYL)CYCLOHEXYLCARBAMATE is used as a key intermediate in the synthesis of C-2 hydroxyethyl imidazopyrrolo pyridines, which are JAK1 inhibitors. These inhibitors play a crucial role in the development of treatments for various inflammatory and autoimmune diseases by targeting the JAK/STAT signaling pathway.
Additionally, TERT-BUTYL TRANS-(4-HYDROXYMETHYL)CYCLOHEXYLCARBAMATE is utilized in the preparation of Mer kinase inhibitors. These inhibitors are specifically designed for the treatment of pediatric acute lymphoblastic leukemia, a type of cancer that predominantly affects children and young adults. By targeting the Mer kinase pathway, these inhibitors aim to halt the uncontrolled growth of cancer cells and provide a potential therapeutic option for patients suffering from this aggressive form of leukemia.

Check Digit Verification of cas no

The CAS Registry Mumber 239074-29-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,3,9,0,7 and 4 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 239074-29:
(8*2)+(7*3)+(6*9)+(5*0)+(4*7)+(3*4)+(2*2)+(1*9)=144
144 % 10 = 4
So 239074-29-4 is a valid CAS Registry Number.
InChI:InChI=1/C12H23NO3/c1-12(2,3)16-11(15)13-10-6-4-9(8-14)5-7-10/h9-10,14H,4-8H2,1-3H3,(H,13,15)/t9-,10-

239074-29-4 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H62487)  trans-1-(Boc-amino)-4-(hydroxymethyl)cyclohexane, 97%   

  • 239074-29-4

  • 1g

  • 538.0CNY

  • Detail
  • Alfa Aesar

  • (H62487)  trans-1-(Boc-amino)-4-(hydroxymethyl)cyclohexane, 97%   

  • 239074-29-4

  • 5g

  • 2016.0CNY

  • Detail
  • Alfa Aesar

  • (H62487)  trans-1-(Boc-amino)-4-(hydroxymethyl)cyclohexane, 97%   

  • 239074-29-4

  • 25g

  • 8064.0CNY

  • Detail

239074-29-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name tert-butyl N-[4-(hydroxymethyl)cyclohexyl]carbamate

1.2 Other means of identification

Product number -
Other names N-tert-butoxy-carbonyl-trans-4-(hydroxymethyl)cyclohexylamine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:239074-29-4 SDS

239074-29-4Relevant articles and documents

Radical hydroxymethylation of alkyl iodides using formaldehyde as a C1 synthon

Caiger, Lewis,Constantin, Timothée,Douglas, James J.,Juliá, Fabio,Leonori, Daniele,Sheikh, Nadeem S.,Sinton, Conar

, p. 10448 - 10454 (2021/08/20)

Radical hydroxymethylation using formaldehyde as a C1 synthon is challenging due to the reversible and endothermic nature of the addition process. Here we report a strategy that couples alkyl iodide building blocks with formaldehyde through the use of photocatalysis and a phosphine additive. Halogen-atom transfer (XAT) from α-aminoalkyl radicals is leveraged to convert the iodide into the corresponding open-shell species, while its following addition to formaldehyde is rendered irreversible by trapping the transient O-radical with PPh3. This event delivers a phosphoranyl radical that re-generates the alkyl radical and provides the hydroxymethylated product.

Discovery of a Gut-Restricted JAK Inhibitor for the Treatment of Inflammatory Bowel Disease

Leonard, Kristi A.,Madge, Lisa A.,Krawczuk, Paul J.,Wang, Aihua,Kreutter, Kevin D.,Bacani, Genesis M.,Chai, Wenying,Smith, Russell C.,Tichenor, Mark S.,Harris, Michael C.,Malaviya, Ravi,Seierstad, Mark,Johnson, Marguerite E.,Venable, Jennifer D.,Kim, Suzie,Hirst, Gavin C.,Mathur, Ashok S.,Rao, Tadimeti S.,Edwards, James P.,Rizzolio, Michele C.,Koudriakova, Tatiana

, p. 2915 - 2929 (2020/04/08)

To identify Janus kinase (JAK) inhibitors that selectively target gastrointestinal tissues with limited systemic exposures, a class of imidazopyrrolopyridines with a range of physical properties was prepared and evaluated. We identified compounds with low intrinsic permeability and determined a correlation between permeability and physicochemical properties, clogP and tPSA, for a subset of compounds. This low intrinsic permeability translated into compounds displaying high colonic exposure and low systemic exposure after oral dosing at 25 mg/kg in mouse. In a mouse PK/PD model, oral dosing of lead compound 2 demonstrated dose-dependent inhibition of pSTAT phosphorylation in colonic explants post-oral dose but low systemic exposure and no measurable systemic pharmacodynamic activity. We thus demonstrate the utility of JAK inhibitors with low intrinsic permeability as a feasible approach to develop gut-restricted, pharmacologically active molecules with a potential advantage over systemically available compounds that are limited by systemic on-target adverse events.

D2 Dopamine Receptor G Protein-Biased Partial Agonists Based on Cariprazine

Shen, Yudao,McCorvy, John D.,Martini, Michael L.,Rodriguiz, Ramona M.,Pogorelov, Vladimir M.,Ward, Karen M.,Wetsel, William C.,Liu, Jing,Roth, Bryan L.,Jin, Jian

, p. 4755 - 4771 (2019/05/08)

Functionally selective G protein-coupled receptor ligands are valuable tools for deciphering the roles of downstream signaling pathways that potentially contribute to therapeutic effects versus side effects. Recently, we discovered both Gi/o-bi

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 239074-29-4